Chu‐Kuang Chou
Kala Pharmaceuticals (United States)(US)Chia-Yi Christian Hospital(TW)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Screening and Detection, Helicobacter pylori-related gastroenterology studies, Gastrointestinal Tumor Research and Treatment, Gastrointestinal disorders and treatments
Most-Cited Works
- → Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis(2016)996 cited
- → Difference in Performance of Fecal Immunochemical Tests With the Same Hemoglobin Cutoff Concentration in a Nationwide Colorectal Cancer Screening Program(2014)109 cited
- → Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection(2018)82 cited
- → Mitochondrial Dysfunction as an Underlying Cause of Skeletal Muscle Disorders(2022)77 cited
- → Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program(2015)72 cited
- → Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection(2016)71 cited